Clinical-stage biotech developing RNA-based therapies to target genetic diseases.
Industry: Health Care
Latest Trade: $11.74 0.00 (0.0%)
First Day Return: -2.5%
Return from IPO: +6.7%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/20/2024 |
Offer Price | $11.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.8 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/10/2024 |
Offer Price | $11.00 |
Price Range $14.00 - $16.00 | |
Offer Shares (mm) | 6.8 |
Deal Size ($mm) | $75 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
Leerink Partners |
more |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2015 |
Employees at IPO | 58 |
Website www.camp4tx.com |